Northwest Biotherapeutics | NWBO - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Northwest Biotherapeutics

Northwest Biotherapeutics reported $15.25M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Agenus AGEN:US USD 77.24M 10.84M
AstraZeneca AZN:LN USD 8.33B 1.78B
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Celldex Therapeutics CLDX:US USD 33.44M 3.94M
CTI Biopharma CTIC:US USD 33.35M 1.33M
Eisai 4523:JP JPY 171.99B 7.01B
Infinity Pharmaceuticals INFI:US USD 12.24M 2.16M
Merck & Co MRK:US USD 10.76B 371M
Mirati Therapeutics MRTX:US USD 200.99M 11.67M
Northwest Biotherapeutics NWBO:US USD 15.25M 6.06M
Pfizer PFE:US USD 11.5B 7.63B
Plus Therapeutics, Inc. CYTX:US USD 5.23M 497K
Roche Holding ROG:VX CHF 25.06B 4.31B